Agenus Inc [NASDAQ: AGEN] plunged by -$0.01 during the normal trading session on while it closed the day at $0.50. The company report on April 5, 2024 at 4:30 PM that Agenus Announces Reverse Stock Split of Common Stock. Agenus Inc. (Nasdaq: AGEN), a leader
Agenus Inc [NASDAQ: AGEN] jumped around 0.01 points on Monday, while shares priced at $0.59 at the close of the session, up 1.29%. Compared to the average trading volume of 10.27M shares, AGEN reached a trading volume of 6832327 in the most recent trading day,
Agenus Inc [NASDAQ: AGEN] traded at a low on Monday, posting a -1.91 loss after which it closed the day’ session at $0.53. The results of the trading session contributed to over 13527174 shares changing hands. Over the past one week, the price volatility of
Agenus Inc [NASDAQ: AGEN] gained 0.49% on the last trading session, reaching $0.67 price per share at the time. The company report on March 6, 2024 at 7:30 AM that Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024. Preclinical findings demonstrate superior pharmacological
Agenus Inc [NASDAQ: AGEN] stock went on a downward path that fall over -1.48% on Friday, amounting to a one-week price decrease of less than -3.23%. The company report on February 29, 2024 at 7:30 AM that Agenus to Provide Corporate Update and Fourth Quarter
Agenus Inc [NASDAQ: AGEN] surged by $0.05 during the normal trading session on while it closed the day at $0.73. The company report on February 26, 2024 at 7:30 AM that Agenus to Participate in Leerink Partners Global Biopharma Conference. Agenus Inc. (“Agenus”) (Nasdaq: AGEN),
Agenus Inc [NASDAQ: AGEN] gained 0.20% or 0.01 points to close at $0.66 with a heavy trading volume of 19611243 shares. The company report on February 15, 2024 at 7:02 AM that Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine
Agenus Inc [NASDAQ: AGEN] traded at a high on Friday, posting a 0.75 gain after which it closed the day’ session at $0.70. The company report on January 31, 2024 at 7:30 AM that Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference.
Agenus Inc [NASDAQ: AGEN] surged by $0.07 during the normal trading session on while it closed the day at $0.70. Agenus Inc stock has also gained 11.18% of its value over the past 7 days. However, AGEN stock has declined by -16.64% in the 3
Agenus Inc [NASDAQ: AGEN] closed the trading session at $0.66. The company report on January 22, 2024 at 9:59 AM that Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population. Botensilimab/Balstilimab (BOT/BAL) shows major tumor
© 2024, Powered by Smart TechOne
